FDA Works To Create Safe Malaria Vaccines

The U.S. Food and Drug Administration said it is entering into a collaboration to create better safety and efficacy tests for experimental malaria vaccines. FDA officials said they are joining with the PATH Malaria Vaccine Initiative that is designed to develop laboratory tests to better predict the level of safety and effectiveness of such vaccines before they are used in human clinical trials. "This collaboration with the PATH-MVI supports the overall mission of the FDA and specifically the agency's work under our Critical Path Initiative," said Dr. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and... [read full story]